Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis (Q28217372)
scientific article
Language:
Current Data About Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis
(P31) (Q13442814)

(P50) (Q64496972)
(P1545) 3
(P1932) Elliott M Antman

(Q60162120)
(P1545) 4
(P1932) Sebastian Schneeweiss

(Q106510275)
(P1545) 5
(P1932) William H Shrank

(Q6183214)
(P1545) 2
(P1932) Jerry Avorn

(Q88688215)
(P1545) 1
(P1932) Niteesh K Choudhry

(P304) 186-94

(P407) (Q1860)

(P433) 1

(P478) 26

(P577) +2007-00-00T00:00:00Z
(P248)

(P921) (Q12152)
(P887)

(P1433) (Q260110)

(P1476) "Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis" (language: en)

other details
description scientific article

External Links
(P356) 10.1377/HLTHAFF.26.1.186
(P698) 17211028
(P3181) 2223815
(P5875) 6590412